Related references
Note: Only part of the references are listed.A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
Sharon B Wigal et al.
Child and Adolescent Psychiatry and Mental Health (2012)
Pharmacokinetics of Lisdexamfetamine Dimesylate and Its Active Metabolite, d-Amphetamine, With Increasing Oral Doses of Lisdexamfetamine Dimesylate in Children With Attention-Deficit/Hyperactivity Disorder: A Single-Dose, Randomized, Open-Label, Crossover Study
Samuel W. Boellner et al.
CLINICAL THERAPEUTICS (2010)
Lisdexamfetamine Dimesylate: Linear Dose-Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open-Label Single-Dose Pharmacokinetic Study in Healthy Adult Volunteers
James Ermer et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Eosinophilic Hepatitis in an Adolescent During Lisdexamfetamine Dimesylate Treatment for ADHD
Brandy Hood et al.
PEDIATRICS (2010)
Review of Medication Adherence in Children and Adults with ADHD
Lisa D. Adler et al.
POSTGRADUATE MEDICINE (2010)
Adverse Reactions to Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder: Structure and Associations with Clinical Characteristics and Symptom Control
Edmund J. S. Sonuga-Barke et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2009)
Three-Year Follow-Up of Syndromal Antisocial Behavior in Adults: Results From the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions
Rise B. Goldstein et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Short-Term Effects of Lisdexamfetamine Dimesylate on Cardiovascular Parameters in a 4-Week Clinical Trial in Adults With Attention-Deficit/Hyperactivity Disorder
Lenard A. Adler et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers
D. R. Jasinski et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse
D. R. Jasinski et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Medication Adherence in the MTA: Saliva Methylphenidate Samples Versus Parent Report and Mediating Effect of Concomitant Behavioral Treatment
Elizabeth Pappadopulos et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2009)
The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety
D. J. Heal et al.
NEUROPHARMACOLOGY (2009)
Poison centers detect an unexpectedly frequent number of adverse drug reactions to lisdexamfetamine
Henry A. Spiller et al.
ANNALS OF PHARMACOTHERAPY (2008)
Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: A scientific statement from the American Heart Association Council on cardiovascular disease in the young congenital cardiac defects committee and the council on cardiovascular nursing
Victoria L. Vetter et al.
CIRCULATION (2008)
Metabolism, Distribution and Elimination of Lisdexamfetamine Dimesylate Open-Label, Single-Centre, Phase I Study in Healthy Adult Volunteers
Suma M. Krishnan et al.
CLINICAL DRUG INVESTIGATION (2008)
Evolution of the treatment of attention-deficit/hyperactivity disorder in children: A review
Robert L. Findling
CLINICAL THERAPEUTICS (2008)
Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder - Epidemiology, prevention and management
Johnny Graham et al.
CNS DRUGS (2008)
Relative bioavailability of lisdexamfetamine 70-mg capsules in fasted and fed healthy adult volunteers and in solution: A single-dose, crossover pharmacokinetic study
Suma Krishnan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
Lenard A. Adler et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
A clinical review of outcomes of the Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (MTA)
Desiree W. Murray et al.
Current Psychiatry Reports (2008)
ADHD, Substance Use Disorders, and Psychostimulant Treatment Current Literature and Treatment Guidelines
Scott H. Kollins
JOURNAL OF ATTENTION DISORDERS (2008)
Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: A double-blind, placebo-controlled, crossover analog classroom study
Joseph Biederman et al.
BIOLOGICAL PSYCHIATRY (2007)
Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder
Steven Pliszka et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2007)
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study
Joseph Biederman et al.
CLINICAL THERAPEUTICS (2007)
An evaluation of the cytochrome P450 inhibition potential of lisdexamfetamine in human liver microsomes
Suma Krishnan et al.
DRUG METABOLISM AND DISPOSITION (2007)
Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder
Richard H. Weisler
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children
Tanya E. Froehlich et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2007)
Illicit use of specific prescription stimulants among college students: Prevalence, motives, and routes of administration
Christian J. Teter et al.
PHARMACOTHERAPY (2006)
New formulations of stimulants for attention-deficit hyperactivity disorder - Therapeutic potential
DF Connor et al.
CNS DRUGS (2004)
Once-a-day concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings
WE Pelham et al.
PEDIATRICS (2001)
Share Paper
